Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Xiong Xia

Showing results (31-40 of 72) with videos related to

Pageof 8
Sort By:
Oral Oncology|June 18, 2017
A phase II trial of induction NAB-paclitaxel and cisplatin followed by concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinomaLiang-Ru Ke, Wei-Xiong Xia, Wen-Ze Qiu, et al.
European Journal of Cancer (Oxford, England : 1990)|April 11, 2013
A prognostic model predicts the risk of distant metastasis and death for patients with nasopharyngeal carcinoma based on pre-treatment serum C-reactive protein and N-classificationWei-Xiong Xia, Hai-Bo Zhang, Jun-Li Shi, et al.
Chinese Journal of Cancer|September 18, 2012
Favorable prognosis of female patients with nasopharyngeal carcinomaXing Lu, Fei-Li Wang, Xiang Guo, et al.
Medical Oncology (Northwood, London, England)|December 21, 2012
Positive effect of high RKIP expression on reduced distant metastasis by chemotherapy when combined with radiotherapy in locoregionally advanced nasopharyngeal carcinoma: a prospective studySi Wei Li, Hua Wang, Mei Lian Liu, et al.
Chinese Journal of Cancer|July 1, 2016
A model to predict the risk of lethal nasopharyngeal necrosis after re-irradiation with intensity-modulated radiotherapy in nasopharyngeal carcinoma patientsYa-Hui Yu, Wei-Xiong Xia, Jun-Li Shi, et al.
Frontiers in Oncology|June 27, 2022
Plasma Circulating Tumor Epstein-Barr Virus for the Surveillance of Cancer Progression in Bone-Only Metastatic Nasopharyngeal CarcinomaGuo-Ying Liu, Wei-Xiong Xia, Zhuo-Fei Bi, et al.
Oncotargets and Therapy|August 31, 2016
Comparison of the short-term efficacy between docetaxel plus carboplatin and 5-fluorouracil plus carboplatin in locoregionally advanced nasopharyngeal carcinomaXing Lv, Wei-Xiong Xia, Liang-Ru Ke, et al.
BMC Cancer|February 17, 2017
Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trialLiang-Ru Ke, Wei-Xiong Xia, Wen-Ze Qiu, et al.
Plos One|October 17, 2013
The impact of baseline serum C-reactive protein and C-reactive protein kinetics on the prognosis of metastatic nasopharyngeal carcinoma patients treated with palliative chemotherapyWei-Xiong Xia, Yan-Fang Ye, Xing Lu, et al.
Plos One|August 11, 2017
A retrospective study of 606 cases of nasopharyngeal carcinoma with or without oropharyngeal candidiasis during radiotherapyWen-Ze Qiu, Liang-Ru Ke, Wei-Xiong Xia, et al.
Pageof 8

Showing results (31-40 of 72) with videos related to

Sort By:
Pageof 8
Oral Oncology|June 18, 2017
A phase II trial of induction NAB-paclitaxel and cisplatin followed by concurrent chemoradiotherapy in patients with locally advanced nasopharyngeal carcinomaLiang-Ru Ke, Wei-Xiong Xia, Wen-Ze Qiu, et al.
European Journal of Cancer (Oxford, England : 1990)|April 11, 2013
A prognostic model predicts the risk of distant metastasis and death for patients with nasopharyngeal carcinoma based on pre-treatment serum C-reactive protein and N-classificationWei-Xiong Xia, Hai-Bo Zhang, Jun-Li Shi, et al.
Chinese Journal of Cancer|September 18, 2012
Favorable prognosis of female patients with nasopharyngeal carcinomaXing Lu, Fei-Li Wang, Xiang Guo, et al.
Medical Oncology (Northwood, London, England)|December 21, 2012
Positive effect of high RKIP expression on reduced distant metastasis by chemotherapy when combined with radiotherapy in locoregionally advanced nasopharyngeal carcinoma: a prospective studySi Wei Li, Hua Wang, Mei Lian Liu, et al.
Chinese Journal of Cancer|July 1, 2016
A model to predict the risk of lethal nasopharyngeal necrosis after re-irradiation with intensity-modulated radiotherapy in nasopharyngeal carcinoma patientsYa-Hui Yu, Wei-Xiong Xia, Jun-Li Shi, et al.
Frontiers in Oncology|June 27, 2022
Plasma Circulating Tumor Epstein-Barr Virus for the Surveillance of Cancer Progression in Bone-Only Metastatic Nasopharyngeal CarcinomaGuo-Ying Liu, Wei-Xiong Xia, Zhuo-Fei Bi, et al.
Oncotargets and Therapy|August 31, 2016
Comparison of the short-term efficacy between docetaxel plus carboplatin and 5-fluorouracil plus carboplatin in locoregionally advanced nasopharyngeal carcinomaXing Lv, Wei-Xiong Xia, Liang-Ru Ke, et al.
BMC Cancer|February 17, 2017
Safety and efficacy of lobaplatin combined with 5-fluorouracil as first-line induction chemotherapy followed by lobaplatin-radiotherapy in locally advanced nasopharyngeal carcinoma: preliminary results of a prospective phase II trialLiang-Ru Ke, Wei-Xiong Xia, Wen-Ze Qiu, et al.
Plos One|October 17, 2013
The impact of baseline serum C-reactive protein and C-reactive protein kinetics on the prognosis of metastatic nasopharyngeal carcinoma patients treated with palliative chemotherapyWei-Xiong Xia, Yan-Fang Ye, Xing Lu, et al.
Plos One|August 11, 2017
A retrospective study of 606 cases of nasopharyngeal carcinoma with or without oropharyngeal candidiasis during radiotherapyWen-Ze Qiu, Liang-Ru Ke, Wei-Xiong Xia, et al.
Pageof 8